Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
The rapid mutation of the SARS-CoV-2 virus is now a major concern with no effective drugs and treatments. The severity of the disease is linked to the induction of a cytokine storm that promotes extensive inflammation in the lung, leading to many acute lung injuries, pulmonary edema, and eventually...
Guardado en:
Autores principales: | Xin Ya Loke, Siti A. M. Imran, Gee Jun Tye, Wan Safwani Wan Kamarul Zaman, Fazlina Nordin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/783949d0e4524b7cba72c0aff69fefcf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis
por: Pino,Ana María, et al.
Publicado: (2012) -
Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues
por: Elena Munoz-Perez, et al.
Publicado: (2021) -
EFFICACY AND SAFETY OF IMMUNOMODULATORS APPLICATION IN PREVENTION OF COMPLICATIONS IN PATIENTS WITH PERTUSSIS
por: L. M. Panasenko, et al.
Publicado: (2012) -
Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report
por: Kátia Nunes da Silva, et al.
Publicado: (2021) -
IMMUNOMODULATORS IN OPPORTUNISTIC INFECTIONS TREATMENT
por: A. P. Toptygina, et al.
Publicado: (2014)